New Delhi: Apollo Hospitals has announced its financial results for Q1 FY27.
- Q1 FY27 Consolidated Revenue grew 21% YoY to Rs. 7,043 Crore.
- Q1 FY27 Consolidated EBITDA grew 28% YoY to Rs. 1,092 Crore.
- Q1 FY27 Consolidated PAT at Rs. 581 Crore.
- Healthcare Services Revenue grew 22% YoY. EBITDA stood at Rs. 862 Crore.
- Apollo Health and Lifestyle Limited Revenue grew 15% to Rs. 499 Crore.
- Apollo HealthCo reported Revenue of Rs. 2,977 Crore and EBITDA of Rs. 171 Crore.
- Revenue growth driven by robust volume increase in Congo T Specialties and high-complexity clinical work.
- Apollo Hospitals continues capacity growth momentum with the launch of a 180-bed hospital in Sarjapur, Bangalore. The Gurugram facility remains on track for commissioning in Q3 FY27.
- Apollo Hospitals also announces the expansion of its existing hospital facilities in Indore & Guwahati by 148 beds and addition of 4 new hospitals in Indore, Dwarka, Delhi Proton Centre and Ranchi, totaling 1,200 beds. With these additions, Apollo Hospitals now has plans to add over 5,800 total beds (4,700 census beds) over the next 5 years.
- The International Patient Services division continued to witness increasing traction, with a YoY revenue growth of 26%, reinforcing Apollo’s position as a preferred global healthcare destination.
Key Clinical Highlights
- Indraprastha Apollo Hospitals, New Delhi: Performed India’s first leadless pacemaker implantation across a prosthetic tricuspid valve, avoiding high-risk repeat open-heart surgery.
- Indraprastha Apollo Hospitals, New Delhi: Performed India’s first reported robotic Whipple procedure in a patient with intestinal nonrotation and periampullary cancer.
- Apollo Hospitals, Kolkata: Performed India’s first native transcatheter tricuspid valve replacement in a patient with inoperable tricuspid regurgitation.
- Apollo BGS Hospitals, Mysuru: Successfully performed laparoscopic adrenalectomy for a hormonally active adrenal myelolipoma, improving blood pressure control.
- Apollo Hospitals, Ahmedabad: Successfully performed complex pulmonary endarterectomy for high-risk chronic thromboembolic pulmonary hypertension despite severe thrombocytopenia.
Dr. Prathap C. Reddy, Founder & Chairman, Apollo Hospitals Group, said:
“Q1 FY27 marks a strong start to the year, building on the momentum of FY26. Consolidated revenue grew 21% year-on-year to ₹7,043 crore, supported by strong-based performance across Healthcare Services, Diagnostics and Retail Health, and Digital Health and Pharmacy. The performance reflects the strength of our integrated model and the continued trust that patients and their families place in Apollo.
I am particularly encouraged by this performance at a time when Indian healthcare is undergoing an important transition. India has made remarkable progress in expanding access to quality healthcare over the past four decades. Institutions like Apollo have both the opportunity and the responsibility to contribute to that transformation. The rising burden of non-communicable diseases and growing need for specialised care require us to move beyond episodic treatment towards a model that connects prevention, early diagnosis, advanced intervention and long-term care.
Apollo’s integrated healthcare ecosystem is well placed to support this shift. Above all, these results reflect the enduring trust that patients and their families place in us. That trust remains our greatest responsibility.
During the quarter, we continued to expand access to advanced care with the commissioning of our hospitals in Sarjapur, Bangalore in Q1 FY27. Apollo now has plans to add over 5,800 total beds over the next 5 years.
Apollo HealthCo continued to pursue profitable and sustainable growth by strengthening its omnichannel pharmacy network and digital healthcare delivery. Together with our diagnostics and retail health businesses, these platforms are making healthcare more convenient, enabling earlier intervention and helping people engage with their health more consistently.
International patient demand remained steady, supported by our engagement with governments, embassies and healthcare partners. The continued confidence of patients from around the world reflects the strength of India’s clinical expertise and reinforces its potential to become a leading global destination for high-quality healthcare.
As we look ahead, we will remain focused on clinical excellence and patient safety, preventive and patient-centric care, disciplined expansion and prudent capital allocation. Growth is meaningful only when it allows us to touch more lives. Apollo will remain steadfast in its founding purpose, to bring world-class healthcare, delivered with compassion, within the reach of every family and to help build a healthier India.”
Q1 FY27 FINANCIAL PERFORMANCE
Consolidated Q1 FY27 Performance
- Revenue at Rs. 7,043 Crore vs. Rs. 5,842 Crore in Q1 FY26; growth of 21% YoY.
- EBITDA at Rs. 1,092 Crore vs. Rs. 852 Crore in Q1 FY26. This is after Apollo 24/7 cost of Rs. 91 Crore in the quarter vs. Rs. 121 Crore in Q1 FY26.
- Reported PAT at Rs. 581 Crore vs. Rs. 433 Crore in Q1 FY26.
- Diluted EPS of Rs. 40.36 per share in Q1 FY27 (not annualized).
Healthcare Services Q1 FY27 Performance
- Revenue at Rs. 3,567 Crore vs. Rs. 2,935 Crore in Q1 FY26; growth of 22% YoY.
- EBITDA at Rs. 862 Crore vs. Rs. 718 Crore in Q1 FY26; growth of 20% YoY; margin at 24%.
- PAT at Rs. 480 Crore vs. Rs. 384 Crore in Q1 FY26; growth of 25% YoY.
Apollo Health and Lifestyle Limited Q1 FY27 Performance
- Revenue at Rs. 499 Crore vs. Rs. 435 Crore in Q1 FY26; growth of 15% YoY.
- EBITDA at Rs. 59 Crore vs. Rs. 40 Crore in Q1 FY26; margin at 12%.
- PAT loss at Rs. 1 Crore vs. PAT loss of Rs. 8 Crore in Q1 FY26.
Apollo HealthCo Q1 FY27 Performance
- Revenue at Rs. 2,977 Crore vs. Rs. 2,472 Crore in Q1 FY26; growth of 20% YoY.
- EBITDA at Rs. 171 Crore vs. Rs. 94 Crore in Q1 FY26; margin at 6%.
- PAT at Rs. 101 Crore vs. Rs. 57 Crore in Q1 FY26.
SEGMENT-WISE PERFORMANCE UPDATE
Healthcare Services (Hospitals)
As on June 30, 2026, Apollo Hospitals had 8,352 operating beds across the network, excluding AHLL and managed beds, with overall occupancy at 70% versus 65% in Q1 FY26. Healthcare Services revenue increased 22% YoY to ₹3,567 crore, while EBITDA (post Ind AS 116) stood at ₹862 crore, up 20% YoY.
The new hospitals with a combined operating capacity of 380 beds in Financial District, Sonarpur, Pune and Delhi Oncology were commissioned in Q4 FY26, and Sarjapur was launched in Q1 FY27. These reported an EBITDA loss of Rs. 38 Cr in Q1 FY27.
Regional Performance
Tamil Nadu: Revenue grew by 16%, IP volumes grew by 13%, and ARPP grew by 5% to Rs. 2,13,309. Overall occupancy was 1,404 beds (70%) compared with 1,261 beds (62%) in Q1 FY26.
AP–Telangana: Revenue grew by 31%, IP volumes grew by 25%, and ARPP grew by 7% to Rs. 1,94,605. Overall occupancy was 948 beds (67%) compared with 813 beds (63%) in Q1 FY26.
Karnataka: Revenue grew by 21%, IP volumes grew by 10%, and ARPP grew by 12% to Rs. 1,96,748. Overall occupancy was 578 beds (70%) compared with 534 beds (69%) in Q1 FY26.
Eastern: Revenue grew by 20%, IP volumes grew by 12%, and ARPP grew by 9% to Rs. 1,58,952. Overall occupancy was 1,460 beds (76%) compared with 1,301 beds (71%) in Q1 FY26.
Western: Revenue grew by 28%, IP volumes grew by 17%, and ARPP grew by 10% to Rs. 1,73,128. Overall occupancy was 543 beds (58%) compared with 465 beds (52%) in Q1 FY26.
Northern: Revenue grew by 16%, IP volumes grew by 6%, and ARPP grew by 10% to Rs. 1,79,989. Overall occupancy was 895 beds (73%) compared with 847 beds (70%) in Q1 FY26.
Apollo Health and Lifestyle Limited (AHLL)
- AHLL gross revenue at Rs. 499 Crore; 15% YoY growth.
- Diagnostics revenue stood at Rs. 200 Crore and Spectra revenue at Rs. 80 Crore.
Apollo HealthCo
- Offline pharmacy distribution revenue stood at ₹2,629 crore and digital platform revenue at ₹348 crore, taking overall HealthCo revenue to ₹2,977 crore, up 20% YoY. The business continued to strengthen its omnichannel pharmacy and digital healthcare platform, with 151 net new stores added during the quarter, taking the network to 7,440 stores.
- Apollo 24/7 GMV stood at ₹535 crore, up 23% YoY, while the average daily order run rate across pharmacy, diagnostics and consultations, including IP/OP referrals, stood at 70K, compared with 64K in Q1 FY26.
The business continued to see healthy performance across the hospital network, supported by growth in inpatient volumes, ARPP and occupancy.
EXPANSION, INNOVATION AND PARTNERSHIPS
During the quarter, Apollo advanced its healthcare expansion and innovation agenda:
- Apollo launched a 180-bed hospital in Sarjapur, Bangalore in Q1 FY27, expanding access to healthcare.
- Health of the Nation 2026: Apollo Hospitals’ latest report maps the changing health risk profile in India, highlighting how health risks are emerging earlier, remaining hidden longer and often being missed.
- Apollo Cancer Centers became the first in India to launch Guardant Health’s Shield™ Multi-Cancer Detection Test, expanding access to advanced cancer screening.
- Apollo Hospitals signed an MoU with the ePlane Company to explore electric air ambulances and medical delivery drones for India’s emergency healthcare network.
AWARDS & ACCOLADES
Apollo Hospitals and its network of hospitals continued to receive recognition for clinical excellence, patient care, operational excellence and quality during the quarter. Key recognitions included:
- Apollo Hospitals, Chennai received the FE Healthcare Awards 2026 recognitions for Excellence in Multispecialty Care – South and Excellence in Emergency & Critical Care – South, and the IHF Award for Hospital Operational Excellence.
- Apollo Children’s Hospital, Chennai was recognised among the World’s Best Hospitals 2026 by Newsweek and Statista and received a CII award for its quality improvement initiative in paediatric epilepsy care.
- Apollo BGS Hospitals, Mysuru received multiple FE Healthcare Awards 2026 recognitions, including Excellence in Inpatient Care & Experience and Premier Stroke Centre of Excellence – South.
- Apollo Hospitals, Bangalore was recognised as India’s first certified Comprehensive Chest Pain and Stroke Centre by the American Heart Association and American Stroke Association, respectively.
- Apollo Hospitals across Nellore, Visakhapatnam, Ahmedabad, Kolkata and Indore received recognitions from CAHO, Six Sigma Healthcare Excellence Awards and other institutions for quality, safety, endoscopy and operational excellence.
- Apollo Hospitals across the network also received recognition for excellence in medical education, sustainability, patient-centricity and responsible use of technology.
CORPORATE SOCIAL RESPONSIBILITY
During Q1 FY 2026–27, Apollo Foundation – Total Health and Billion Hearts Beating Foundation together reached over 2.35 lakh beneficiaries through integrated healthcare, preventive health, community development and social support initiatives.
Total Health reached 1,23,967 beneficiaries, including through the launch of the Rural Integrated Community Development Project in Meghalaya and the completion of a Model Anganwadi Centre in Pithapuram.
Billion Hearts Beating reached 1,11,935 beneficiaries through community care, senior citizen support, health camps and emergency care training.
Together, these initiatives underscore Apollo’s continued commitment to improving health outcomes and building healthier, more resilient communities through sustainable interventions.
